Robust anonymized longitudinal patient data uncovers treatment patterns that can be used to refine and target messaging to prescribers. Concomitant conditions, brand switching, dose titration, and other specifics of treatment can be segmented to understand where physicians position your brand. This understanding of current product use at a patient-specific level supports gap analysis and development of messaging to uncover clinical roadblocks and expand utilization.
PatientSource™ helps address key questions about how patients are participating in treatment:
Patient-centric analysis also supports a deeper understanding of market factors that impact brands:
We love to hear from our customers and industry followers. To share your thought, idea or message with our leadership team, please visit our contact page.Contact Us